Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients.

Published on May 1, 2012in Pancreatology3.629
· DOI :10.1016/J.PAN.2012.03.055
Sönke Detlefsen21
Estimated H-index: 21
(OUH: Odense University Hospital),
Giuseppe Zamboni81
Estimated H-index: 81
(University of Verona)
+ 6 AuthorsGünter Klöppel38
Estimated H-index: 38
(TUM: Technische Universität München)
Abstract Background At the recent consensus conference on autoimmune pancreatitis (AIP) in Honolulu, we presented preliminary data from our study of surgically treated AIP patients. Our data strongly supported the separation of AIP into type 1 and type 2. Our study is based on a total of 114 surgically treated European AIP patients. Our aims were to elucidate serum IgG4 elevation, other organ involvement, relapse of disease, steroid treatment and diabetes after surgery in 114 surgically treated European AIP patients. Methods 88 pancreaticoduodenectomies, 22 left-sided resections and 4 total pancreatectomies were examined. All cases were graded for granulocytic epithelial lesions, IgG4-positive cells, storiform fibrosis, phlebitis and eosinophilic granulocytes. Follow-up data were obtained from 102/114 patients, mean follow-up was 5.3 years. Results Histologically, 63 (55.3%) of the 114 patients fulfilled the criteria of type 1 AIP, while 51 (44.7%) patients fulfilled the criteria of type 2 AIP. Type 1 AIP patients were older and more often males than type 2 AIP patients. Elevation of serum IgG4, involvement of extrapancreatic organs, disease relapse, systemic steroid treatment and diabetes after surgery were noted more often in type 1 AIP, while inflammatory bowel disease (IBD) was observed mainly in type 2 AIP. Conclusions Histological typing of AIP is clinically important because type 1 AIP is part of the IgG4-related disease and type 2 AIP is associated with IBD. Our data also show that relapse of disease and steroid treatment after surgery occur more frequently in type 1 than in type 2 AIP.
📖 Papers frequently viewed together
14 Authors (Tooru Shimosegawa, ..., Lizhi Zhang)
959 Citations
523 Citations
1,163 Citations
#1Motohisa Yamamoto (Sapporo Medical University)H-Index: 41
#2Hiroki Takahashi (Sapporo Medical University)H-Index: 62
Last. Yasuhisa Shinomura (Sapporo Medical University)H-Index: 82
view all 13 authors...
IgG4-related disease (IgG4-RD) is considered a systemic, chronic, and inflammatory disorder that is characterized by the enlargement of involved organs, elevated levels of IgG4, and abundant infiltration of plasmacytes with IgG4 and fibrosis in involved organs. It is necessary to differentiate IgG4-RD from malignant tumors. Recently we have looked at case reports of IgG4-RD with malignancy that was discovered at systemic screening. In this study, we analyzed the relationship between IgG4-RD and ...
209 CitationsSource
#1Lizhi Zhang (Mayo Clinic)H-Index: 54
#2Suresh T. ChariH-Index: 103
Last. Yoh Zen (University of Cambridge)H-Index: 87
view all 14 authors...
OBJECTIVES:: To develop and validate histologic diagnostic criteria for autoimmune pancreatitis (AIP) and its types. METHODS:: Thirteen pathologists participated in this 2-phase study to develop diagnostic criteria for AIP types 1 and 2 (phase 1) and validate them (phase 2). A virtual library of 40 resected pancreata with AIP and other forms of chronic pancreatitis (CP) was constructed. Readers reviewed the slides online and filled out a questionnaire for histopathologic findings and diagnosis. ...
97 CitationsSource
#1Michael J. LevyH-Index: 107
#2Thomas C. Smyrk (Mayo Clinic)H-Index: 116
Last. Suresh T. ChariH-Index: 103
view all 5 authors...
Background/Aims: Recent data demonstrate the presence of two autoimmune pancreatitis (AIP) subtypes. All existing endoscopic ultrasonography-guided trucut biopsy (EUS-TCB) data pert
34 CitationsSource
#1Sönke DetlefsenH-Index: 21
#2J.-Matthias Löhr (KI: Karolinska Institutet)H-Index: 19
Last. Günter Klöppel (TUM: Technische Universität München)H-Index: 38
view all 5 authors...
Since the 1990s, autoimmune pancreatitis (AIP) has been increasingly recognized as a special type of chronic pancreatitis. Clinically, AIP patients commonly present with jaundice, weight loss and abdominal pain. Radiologically, there is diffuse or focal enlargement of the pancreas, often with narrowing of the pancreas and bile duct. Histologically, AIP is characterized by periductal infiltrates of lymphocytes and plasma cells, cellular fibrosis and obliterative phlebitis. Recently, two types of ...
13 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 77
#2Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
Last. Gourdas ChoudhuriH-Index: 29
view all 12 authors...
Objectives:To clarify the clinical and pathophysiological characteristics of autoimmune pancreatitis (AIP) in Asia.Methods:A retrospective, actual situation survey of AIP diagnosed by Asian criteria was conducted in 10 centers of Japan, Korea, Taiwan, China, and India.Results:A total of 327 AIP case
80 CitationsSource
#1Vikram Deshpande (Harvard University)H-Index: 120
#2Rajib K Gupta (Harvard University)H-Index: 7
Last. Gregory Y. Lauwers (Harvard University)H-Index: 100
view all 9 authors...
Autoimmune pancreatitis (AIP) is a chronic inflammatory disease of the pancreas. Examination of pancreatic resection specimens from patients with AIP has shown that there are 2 subclasses of this disease. However, there is no widely accepted pathologic classification scheme and the clinical significance of such a classification remains to be established. In this study, we revisited the subclassification of AIP and examine whether this provides clinically and prognostically meaningful information...
143 CitationsSource
#1Frédérique Maire (Beaujon Hospital)H-Index: 32
#2Yann Le BaleurH-Index: 3
Last. Pascal Hammel (Beaujon Hospital)H-Index: 86
view all 11 authors...
OBJECTIVES:Autoimmune pancreatitis (AIP) is better described than before, but there is still no international consensus for definition, diagnosis, and treatment. Our aims were to analyze the short- and long-term outcome of patients with focus on pancreatic endocrine and exocrine functions, to search
141 CitationsSource
#1Martin LoosH-Index: 14
#2Irene EspositoH-Index: 70
Last. Peter BüchlerH-Index: 31
view all 8 authors...
We present the case of a 67-year-old woman who developed a metastatic adenocarcinoma of the pancreatobiliary system shortly after the histologically confirmed diagnosis of autoimmune pancreatitis (AIP). This case highlights the need for increased alertness not only in differentiating AIP from pancreatic cancer at the time of diagnosis, but also to exclude concomitant malignancies of the pancreatobiliary system in the management of histologically confirmed AIP.
35 CitationsSource
#1J.-Matthias Löhr (DKFZ: German Cancer Research Center)H-Index: 19
#2Ralf Faissner (DKFZ: German Cancer Research Center)H-Index: 8
Last. Günter Klöppel (CAU: University of Kiel)H-Index: 108
view all 27 authors...
Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
105 CitationsSource
#1Raghuwansh P. Sah (Mayo Clinic)H-Index: 20
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Santhi Swaroop Vege (Mayo Clinic)H-Index: 50
view all 13 authors...
Background & Aims Autoimmune pancreatitis (AIP) has been divided into subtypes 1 (lymphoplasmacytic sclerosing pancreatitis) and 2 (idiopathic duct centric pancreatitis). We compared clinical profiles and long-term outcomes of types 1 and 2 AIP. Methods We compared clinical presentation, relapse, and vital status of 78 patients with type 1 AIP who met the original HISORt criteria and 19 patients with histologically confirmed type 2 AIP. Results At presentation, patients with type 1 AIP were olde...
318 CitationsSource
Cited By62
Last. Kam A. Newman (UCR: University of California, Riverside)H-Index: 9
view all 5 authors...
Objectives: IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder affecting virtually any organ. Type 1 autoimmune (type 1 AIP) is its pancreatic manifestation. To date, steroids are considered the first-line pancreatitis treatment. The CD20-binding antibody rituximab (RTX) appears a promising steroid-sparing therapy, although long-term data are lacking. We aimed to bridge this gap with a cohort of IgG4-RD patients treated with RTX and to assess the potential value of the Respo...
3 CitationsSource
#1Sönke Detlefsen (University of Southern Denmark)H-Index: 21
#2Søren Schou Olesen (AAU: Aalborg University)H-Index: 28
Abstract Autoimmune pancreatitis (AIP) is a distinct form of chronic pancreatitis that has been increasingly recognised over the last decades and shows a good response to corticosteroid treatment. Two different forms of AIP have been characterized. Type 1 AIP is the pancreatic manifestation of IgG4-related disease and often affects multiple organ systems. In contrast, type 2 AIP is confined to the pancreas and involvement of extra-pancreatic organs has previously only very rarely been reported, ...
#1Robbie R. Goodman (U of T: University of Toronto)H-Index: 1
#2Madelaine K. Jong (U of T: University of Toronto)H-Index: 1
Last. John E. Davies (U of T: University of Toronto)H-Index: 55
view all 3 authors...
Abstract To date only small animal models have been employed to assess the effect of mesenchymal stromal cell (MSC) therapy on acute pancreatitis (AP), the most common cause of hospitalization for gastrointestinal diseases worldwide. We outline the challenges inherent in the small animal models of AP. We also point to specific benefits afforded by the adoption of larger animal models. The potential for MSC therapeutics in the treatment of AP was recognized over a decade ago. With sharper focus o...
5 CitationsSource
#1J-Matthias Löhr (Karolinska University Hospital)H-Index: 11
#2Ulrich Beuers (UvA: University of Amsterdam)H-Index: 78
Last. Heiko Witt (TUM: Technische Universität München)H-Index: 44
view all 35 authors...
The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children. IgG4-related digestive disease can be diagnosed only with a comprehensive work-up that includes histology, organ morphology at imaging, serology, search for other organ involvement, and response to glucocorticoid treatment. Indications for treatment are symptomatic patients with obstructive jaundice, ...
29 CitationsSource
#1Luca Barresi (ISMETT)H-Index: 22
#2Matteo Tacelli (ISMETT)H-Index: 5
Last. EndoscopistsH-Index: 1
view all 29 authors...
BackgroundAutoimmune pancreatitis (AIP) is a rare, and relatively new, form of chronic pancreatitis. The management of AIP can vary considerably among different centres in daily clinical practice.O...
8 CitationsSource
#1Gitte Hedegaard Jensen (OUH: Odense University Hospital)H-Index: 1
#2Michael Bau Mortensen (University of Southern Denmark)H-Index: 20
Last. Sönke Detlefsen (University of Southern Denmark)H-Index: 21
view all 6 authors...
Abstract Morphology plays an important role in the distinction of autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC). However, we aimed to determine the utility of immunohistochemical tumor markers to contribute in the distinction of these entities. In surgical specimens with AIP (n = 20), PDAC (n = 20) and normal pancreas (n = 20), the expression of pVHL, maspin, IMP3, S100 P and Ki67 was examined. We evaluated intralobular reactive ducts / acinoductal metaplasia (ILDs) ...
2 CitationsSource
Autoimmune pancreatitis (AIP), a unique subtype of pancreatitis, is often accompanied by systemic inflammatory disorders. AIP is classified into two distinct subtypes on the basis of the histological subtype: immunoglobulin G4 (IgG4)-related lymphoplasmacytic sclerosing pancreatitis (type 1) and idiopathic duct-centric pancreatitis (type 2). Type 1 AIP is often accompanied by systemic lesions, biliary strictures, hepatic inflammatory pseudotumors, interstitial pneumonia and nephritis, dacryoaden...
9 CitationsSource
Bei dem als „IgG4-assoziierte Erkrankung“ bezeichneten Krankheitsbild handelt es sich um einen potenziell systemischen, chronisch entzundlichen und fibrosierenden Prozess. Unabhangig von der Organmanifestation sind die histologischen Hauptmerkmale ein lymphoplasmazellulares Infiltrat, eine storiforme Fibrose und eine obliterative Phlebitis. Diese Hauptmerkmale werden jedoch in bestimmten Organen unterschiedlich gewichtet. Wenn mehrere dieser Merkmale vorliegen bei Abwesenheit von Veranderungen, ...